Hypothermic Ex Situ Perfusion of Human Limbs With Acellular Solution for 24 Hours.
Journal
Transplantation
ISSN: 1534-6080
Titre abrégé: Transplantation
Pays: United States
ID NLM: 0132144
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
14
3
2020
medline:
7
10
2020
entrez:
14
3
2020
Statut:
ppublish
Résumé
Machine perfusion (MP) has evolved as a promising approach for the ex situ preservation in organ transplantation. However, the literature on the use of MP in human vascularized composite allografts is scarce. The aim of this study was to evaluate the effects of hypothermic MP with an acellular perfusate in human upper extremities and compare with the current gold standard of static cold storage (SCS). Six upper extremities were assigned to either MP (n = 3) or SCS (n = 3) conditions for 24 h. MP-extremities were perfused with oxygenated Steen solution at a constant pressure of 30 mm Hg and 10°C. Median total ischemia time was 213 min (range, 127-222 min). Myoglobin, creatine-kinase (CK) showed increased levels at the start of MP (medians: myoglobin: 4377 ng/mL, CK: 1442 U/L), peaking 6 h after perfusate exchange (medians: myoglobin: 9206 ng/mL, CK: 3995 U/L) at timepoint 24. Lactate levels decreased from a median of 6.9-2.8 mmol/L over time. Expression of hypoxia-inducible factor 1-alpha peaked in the SCS-group after 8 h, followed by a decrease. Increased hypoxia-inducible factor 1-alpha expression in the MP group was delayed until 20 h. Perfusion pressure, temperature, and circuit flow were maintained at median of 30.88 mm Hg, 9.77°C, and 31.13 mL/min, respectively. Weight increased 1.4% in the SCS group and 4.3% in the MP group over 24 h. Hypothermic ex situ perfusion with an oxygenated acellular Steen solution may extend the allowable extracorporeal preservation time by a factor of 4-6 compared to SCS and holds promise to be beneficial for vascularized composite allograft recipients and victims of traumatic major limb amputation.
Sections du résumé
BACKGROUND
Machine perfusion (MP) has evolved as a promising approach for the ex situ preservation in organ transplantation. However, the literature on the use of MP in human vascularized composite allografts is scarce. The aim of this study was to evaluate the effects of hypothermic MP with an acellular perfusate in human upper extremities and compare with the current gold standard of static cold storage (SCS).
METHODS
Six upper extremities were assigned to either MP (n = 3) or SCS (n = 3) conditions for 24 h. MP-extremities were perfused with oxygenated Steen solution at a constant pressure of 30 mm Hg and 10°C.
RESULTS
Median total ischemia time was 213 min (range, 127-222 min). Myoglobin, creatine-kinase (CK) showed increased levels at the start of MP (medians: myoglobin: 4377 ng/mL, CK: 1442 U/L), peaking 6 h after perfusate exchange (medians: myoglobin: 9206 ng/mL, CK: 3995 U/L) at timepoint 24. Lactate levels decreased from a median of 6.9-2.8 mmol/L over time. Expression of hypoxia-inducible factor 1-alpha peaked in the SCS-group after 8 h, followed by a decrease. Increased hypoxia-inducible factor 1-alpha expression in the MP group was delayed until 20 h. Perfusion pressure, temperature, and circuit flow were maintained at median of 30.88 mm Hg, 9.77°C, and 31.13 mL/min, respectively. Weight increased 1.4% in the SCS group and 4.3% in the MP group over 24 h.
CONCLUSIONS
Hypothermic ex situ perfusion with an oxygenated acellular Steen solution may extend the allowable extracorporeal preservation time by a factor of 4-6 compared to SCS and holds promise to be beneficial for vascularized composite allograft recipients and victims of traumatic major limb amputation.
Identifiants
pubmed: 32168040
doi: 10.1097/TP.0000000000003221
pii: 00007890-202009000-00020
doi:
Substances chimiques
Cytokines
0
Organ Preservation Solutions
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e260-e270Références
Chaui-Berlinck JG, Monteiro LH, Navas CA, et al. Temperature effects on energy metabolism: a dynamic system analysis. Proc Biol Sci. 2002; 269:15–19. doi:10.1098/rspb.2001.1845
doi: 10.1098/rspb.2001.1845
Harris K, Walker PM, Mickle DA, et al. Metabolic response of skeletal muscle to ischemia. Am J Physiol. 1986; 2502 Pt 2H213–H220. doi:10.1152/ajpheart.1986.250.2.H213
doi: 10.1152/ajpheart.1986.250.2.H213
Krezdorn N, Tasigiorgos S, Wo L, et al. Tissue conservation for transplantation. Innov Surg Sci. 2017; 2:171–187. doi:10.1515/iss-2017-0010
doi: 10.1515/iss-2017-0010
Amin KR, Wong JKF, Fildes JE. Strategies to reduce ischemia reperfusion injury in vascularized composite allotransplantation of the limb. J Hand Surg Am. 2017; 42:1019–1024. doi:10.1016/j.jhsa.2017.09.013
doi: 10.1016/j.jhsa.2017.09.013
Müller S, Constantinescu MA, Kiermeir DM, et al. Ischemia/reperfusion injury of porcine limbs after extracorporeal perfusion. J Surg Res. 2013; 181:170–182. doi:10.1016/j.jss.2012.05.088
doi: 10.1016/j.jss.2012.05.088
Messner F, Grahammer J, Hautz T, et al. Ischemia/reperfusion injury in vascularized tissue allotransplantation: tissue damage and clinical relevance. Curr Opin Organ Transplant. 2016; 21:503–509. doi:10.1097/MOT.0000000000000343
doi: 10.1097/MOT.0000000000000343
Werner NL, Alghanem F, Rakestraw SL, et al. Ex situ perfusion of human limb allografts for 24 hours. Transplantation. 2017; 101:e68–e74. doi:10.1097/TP.0000000000001500
doi: 10.1097/TP.0000000000001500
Blaisdell FW. The pathophysiology of skeletal muscle ischemia and the reperfusion syndrome: a review. Cardiovasc Surg. 2002; 10:620–630. doi:10.1016/s0967-2109(02)00070-4
doi: 10.1016/s0967-2109(02)00070-4
Dutkowski P, Schlegel A, de Oliveira M, et al. HOPE for human liver grafts obtained from donors after cardiac death. J Hepatol. 2014; 60:765–772. doi:10.1016/j.jhep.2013.11.023
doi: 10.1016/j.jhep.2013.11.023
Brockmann J, Reddy S, Coussios C, et al. Normothermic perfusion: a new paradigm for organ preservation. Ann Surg. 2009; 250:1–6. doi:10.1097/SLA.0b013e3181a63c10
doi: 10.1097/SLA.0b013e3181a63c10
Imber CJ, St Peter SD, Lopez de Cenarruzabeitia I, et al. Advantages of normothermic perfusion over cold storage in liver preservation. Transplantation. 2002; 73:701–709. doi:10.1097/00007890-200203150-00008
doi: 10.1097/00007890-200203150-00008
Araki J, Sakai H, Takeuchi D, et al. Normothermic preservation of the rat hind limb with artificial oxygen-carrying hemoglobin vesicles. Transplantation. 2015; 99:687–692. doi:10.1097/TP.0000000000000528
doi: 10.1097/TP.0000000000000528
Duraes EFR, Madajka M, Frautschi R, et al. Developing a protocol for normothermic ex-situ limb perfusion. Microsurgery. 2018; 38:185–194. doi:10.1002/micr.30252
doi: 10.1002/micr.30252
Kueckelhaus M, Fischer S, Sisk G, et al. A mobile extracorporeal extremity salvage system for replantation and transplantation. Ann Plast Surg. 2016; 76:355–360. doi:10.1097/SAP.0000000000000681
doi: 10.1097/SAP.0000000000000681
Kueckelhaus M, Dermietzel A, Alhefzi M, et al. Acellular hypothermic extracorporeal perfusion extends allowable ischemia time in a porcine whole limb replantation model. Plast Reconstr Surg. 2017; 139:922e–932e. doi:10.1097/PRS.0000000000003208
doi: 10.1097/PRS.0000000000003208
Gok E, Alghanem F, Moon R, et al. Development of an ex-situ limb perfusion system for a rodent model. Asaio J. 2019; 65:167–172. doi:10.1097/MAT.0000000000000786
doi: 10.1097/MAT.0000000000000786
Taeger CD, Lamby P, Dolderer J, et al. Extracorporeal perfusion for salvage of major amputates. Ann Surg. 2019; 270:e5–e6. doi:10.1097/SLA.0000000000003226
doi: 10.1097/SLA.0000000000003226
Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med. 1996; 334:1685–1690. doi:10.1056/NEJM199606273342601
doi: 10.1056/NEJM199606273342601
Rees L, Kim JJ. HLA sensitisation: can it be prevented? Pediatr Nephrol. 2015; 30:577–587. doi:10.1007/s00467-014-2868-6
doi: 10.1007/s00467-014-2868-6
Knowles S. Blood transfusion: challenges and limitations Transfus Altern Transfus Med. 2007; 9:2–9. doi:10.1111/j.1778-428X.2007.00062.x
doi: 10.1111/j.1778-428X.2007.00062.x
Ng MSY, David M, Middelburg RA, et al. Transfusion of packed red blood cells at the end of shelf life is associated with increased risk of mortality– a pooled patient data analysis of 16 observational trials. Haematologica. 2018; 103:1542–1548. doi:10.3324/haematol.2018.191932
doi: 10.3324/haematol.2018.191932
Becker S, Steinmeyer J, Avsar M, et al. Evaluating acellular versus cellular perfusate composition during prolonged ex vivo lung perfusion after initial cold ischaemia for 24 hours. Transpl Int. 2016; 29:88–97. doi:10.1111/tri.12649
doi: 10.1111/tri.12649
Paulus P, Holfeld J, Urbschat A, et al. Prednisolone as preservation additive prevents from ischemia reperfusion injury in a rat model of orthotopic lung transplantation. PLoS One. 2013; 8:e73298. doi:10.1371/journal.pone.0073298
doi: 10.1371/journal.pone.0073298
Schneider CA, Rasband WS, Eliceiri KW. NIH image to imagej: 25 years of image analysis. Nat Methods. 2012; 9:671–675. doi:10.1038/nmeth.2089
doi: 10.1038/nmeth.2089
Inagi K, Connor NP, Ford CN, et al. Physiologic assessment of botulinum toxin effects in the rat larynx. Laryngoscope. 1998; 108:1048–1054. doi:10.1097/00005537-199807000-00018
doi: 10.1097/00005537-199807000-00018
Wilson DH, Rissin DM, Kan CW, et al. The Simoa HD-1 analyzer: a novel fully automated digital immunoassay analyzer with single-molecule sensitivity and multiplexing. J Lab Autom. 2016; 21:533–547. doi:10.1177/2211068215589580
doi: 10.1177/2211068215589580
Wu D, Dinh TL, Bausk BP, et al. Long-term measurements of human inflammatory cytokines reveal complex baseline variations between individuals. Am J Pathol. 2017; 187:2620–2626. doi:10.1016/j.ajpath.2017.08.007
doi: 10.1016/j.ajpath.2017.08.007
Krezdorn N, Macleod F, Tasigiorgos S, et al. Twenty-four-hour ex vivo perfusion with acellular solution enables successful replantation of porcine forelimbs. Plast Reconstr Surg. 2019; 144:608e–618e. doi:10.1097/PRS.0000000000006084
doi: 10.1097/PRS.0000000000006084
Ben-Amotz O, Kruger EA, McAndrew C, et al. Logistics in coordinating the first adult transatlantic bilateral hand transplant: lessons learned. Plast Reconstr Surg. 2018; 142:730–735. doi:10.1097/PRS.0000000000004672
doi: 10.1097/PRS.0000000000004672
de With MC, van der Heijden EP, van Oosterhout MF, et al. Contractile and morphological properties of hamster retractor muscle following 16 h of cold preservation. Cryobiology. 2009; 59:308–316. doi:10.1016/j.cryobiol.2009.08.008
doi: 10.1016/j.cryobiol.2009.08.008
Hautz T, Hickethier T, Blumer MJ, et al. Histomorphometric evaluation of ischemia-reperfusion injury and the effect of preservation solutions histidine-tryptophan-ketoglutarate and University of Wisconsin in limb transplantation. Transplantation. 2014; 98:713–720. doi:10.1097/TP.0000000000000300
doi: 10.1097/TP.0000000000000300
Lovic A, Landin L, Diez J, et al. Outcomes with respect to disabilities of the upper limb after hand allograft transplantation: a systematic review Transpl Int. 2012; 25:424–432. doi:10.1111/j.1432-2277.2012.01433.x
doi: 10.1111/j.1432-2277.2012.01433.x
Landin L, Cavadas PC, Garcia-Cosmes P, et al. Perioperative ischemic injury and fibrotic degeneration of muscle in a forearm allograft: functional follow-up at 32 months post transplantation. Ann Plast Surg. 2011; 66:202–209. doi:10.1097/SAP.0b013e318206a365
doi: 10.1097/SAP.0b013e318206a365
Fries CA, Villamaria CY, Spencer JR, et al. A hyperbaric warm perfusion system preserves tissue composites ex vivo and delays the onset of acute rejection. J Reconstr Microsurg. 2019; 35:97–107. doi:10.1055/s-0038-1667298
doi: 10.1055/s-0038-1667298
Wang LC, Lawson SD, Fries CA, et al. Hyperbaric sub-normothermic ex-vivo perfusion delays the onset of acute rejection in a porcine VCA model Plast Reconstr Surg. 2015; 1364S34. doi:10.1097/01.prs.0000472317.36007.b1
doi: 10.1097/01.prs.0000472317.36007.b1
Petruzzo P, Sardu C, Lanzetta M, et al. Report (2017) of the International Registry on Hand and Composite Tissue Allotransplantation (IRHCTT) Curr Transplant Reports. 2017; 4:294–303. doi:10.1007/s40472-017-0168-3
doi: 10.1007/s40472-017-0168-3
Peng YP, Lahiri A. Spare-part surgery. Semin Plast Surg. 2013; 27:190–197. doi:10.1055/s-0033-1360586
doi: 10.1055/s-0033-1360586
Ozer K, Rojas-Pena A, Mendias CL, et al. The effect of ex situ perfusion in a swine limb vascularized composite tissue allograft on survival up to 24 hours. J Hand Surg Am. 2016; 41:3–12. doi:10.1016/j.jhsa.2015.11.003
doi: 10.1016/j.jhsa.2015.11.003
Nickkholgh A, Nikdad M, Shafie S, et al. Ex situ liver machine perfusion as an emerging graft protective strategy in clinical liver transplantation: the dawn of a new era. Transplantation. 2019; 103:2003–2011. doi:10.1097/TP.0000000000002772
doi: 10.1097/TP.0000000000002772
Nasralla D, Coussios CC, Mergental H, et al.; Consortium for Organ Preservation in Europe. A randomized trial of normothermic preservation in liver transplantation. Nature. 2018; 557:50–56. doi:10.1038/s41586-018-0047-9
doi: 10.1038/s41586-018-0047-9
Slater NJ, Zegers HJH, Küsters B, et al. Ex-vivo oxygenated perfusion of free flaps during ischemia time: a feasibility study in a porcine model and preliminary results. J Surg Res. 2016; 205:292–295. doi:10.1016/j.jss.2016.06.096
doi: 10.1016/j.jss.2016.06.096
Ozer K, Rojas-Pena A, Mendias CL, et al. Ex situ limb perfusion system to extend vascularized composite tissue allograft survival in swine. Transplantation. 2015; 99:2095–2101. doi:10.1097/TP.0000000000000756
doi: 10.1097/TP.0000000000000756
Erjavec N, Pinato G, Ramser K. Raman spectroscopy as a tool for detecting mitochondrial fitness J Raman Spectrosc. 2016; 47:933–939. doi:10.1002/jrs.4930
doi: 10.1002/jrs.4930
Abdul-Ghani MA, DeFronzo RA. Pathogenesis of insulin resistance in skeletal muscle. J Biomed Biotechnol. 2010; 2010:476279. doi:10.1155/2010/476279
doi: 10.1155/2010/476279